FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds of formula (I) and its pharmaceutically acceptable salts possessing dihydroorotate dehydrogenase inhibitory ability, to a based pharmaceutical composition, to application thereof in preparing a drug compound and to a combined preparation containing the presented compounds and the other active compound (I) in effective amounts wherein both groups G1 mean CRC, G2 mean a nitrogen atom or group CRd, of the groups G3 and G4 mean a nitrogen atom and the other one means group CH, M means a hydrogen atom or a pharmaceutically acceptable cation, while R1, R2, Ra, Rb, Rc and Rd have the values specified in the patent claim.
EFFECT: preparing pharmaceutically acceptable salts possessing dihydroorotate dehydrogenase inhibitory ability.
25 cl, 115 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PROTEIN TYROSINE KINASE ACTIVITY INHIBITORS | 2009 |
|
RU2533827C2 |
BIPHENYLOXYACETIC ACID DERIVATIVES, USE THEREOF IN PREPARING MEDICINAL AGENT AND INTERMEDIATE COMPOUNDS | 2006 |
|
RU2424229C2 |
NAPHTHYLACETIC ACIDS | 2009 |
|
RU2539185C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
AROMATASE INHIBITORS | 2010 |
|
RU2572244C2 |
PHARMACEUTICAL COMPOUNDS | 2018 |
|
RU2773444C2 |
PHENICOL ANTIBACTERIAL AGENTS | 2013 |
|
RU2593204C2 |
CARBOXYLIC ACIDS COMPOUNDS | 2013 |
|
RU2636146C2 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
COMPOUNDS APPLICABLE FOR TREATING AIDS | 2010 |
|
RU2575845C2 |
Authors
Dates
2012-12-10—Published
2007-12-21—Filed